Keywords: nps, pharmaceuticals, allelix, canada, agree, merge, bid
NPS Pharmaceuticals and Allelix of Canada agree to merge in bid to cut costs
Article | 30 September 1999
NPS Pharmaceuticals of Salt Lake City, USA, and the Toronto, Canada-based firm Allelix Biopharmaceuticals have signed a definitive agreement to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
